Research communication attracts funders, increases opportunities for multi-institutional collaborations and mu...Read more
Breathing difficulties are an issue that affects millions of people every day, all around the world. It might ...Read more
Amidst the pandemic, the Indian Biopharma Industry, with over 300 companies, has witnessed a good growth of 13...Read more
A state-of-the-art Technology Incubator Centre (TIC) with an incubation space of 1,00,000 sq ft has been ...Read more
PerkinElmer has announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer G...Read more
MedLern and BMJ Publishing Group (British Medical Journal publishing group) have teamed up to provide via its ...Read more
Whether you are a mother who has been out of the workplace for one year or ten years, the thought of restartin...Read more
Amidst the pandemic, the Indian Biopharma Industry, with over 300 companies, has witnessed a good growth of 13 percent, 2 percent less than the previous year’s 15 percent growth rate. This growth was largely driven by the performance of the Indian biopharma companies which have done very well as against multinational companies. As a result, the Indian Biopharma Industry has crossed the Rs 33,000 crore mark for the year 2020-21 over the previous year’s figure of Rs 29,176 crore. The Indian Biopharma industry, comprising hormones, insulin, blood products, and vaccines recorded a sales revenue of Rs 33,067 crore for the year 2020-21.